BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3701641)

  • 1. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
    Durham S; Vore M
    J Pharmacol Exp Ther; 1986 May; 237(2):490-5. PubMed ID: 3701641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxic effects of estradiol-17 beta-D-glucuronide in the rat and monkey.
    Slikker W; Vore M; Bailey JR; Meyers M; Montgomery C
    J Pharmacol Exp Ther; 1983 Apr; 225(1):138-43. PubMed ID: 6300372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine triphosphate-dependent transport of estradiol-17beta(beta-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells.
    Huang L; Hoffman T; Vore M
    Hepatology; 1998 Nov; 28(5):1371-7. PubMed ID: 9794924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of estradiol-17 beta-glucuronide in the rat.
    Takikawa H; Yamazaki R; Sano N; Yamanaka M
    Hepatology; 1996 Mar; 23(3):607-13. PubMed ID: 8617443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
    Meyers M; Slikker W; Pascoe G; Vore M
    J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
    Vore M; Durham S; Yeh S; Ganguly T
    Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
    Liu Y; Huang L; Hoffman T; Gosland M; Vore M
    Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interaction between estrogen metabolites and taurocholate for uptake into isolated hepatocytes. Lack of correlation between cholestasis and inhibition of taurocholate uptake.
    Brock WJ; Durham S; Vore M
    J Steroid Biochem; 1984 May; 20(5):1181-5. PubMed ID: 6727367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pregnancy and treatment with 17 beta-estradiol on the transport of organic anions into isolated rat hepatocytes.
    Brock WJ; Vore M
    Drug Metab Dispos; 1984; 12(6):713-6. PubMed ID: 6150820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium and chloride dependency of dibucaine- and procaine-induced choleresis in isolated perfused rat livers.
    Anwer MS; Hegner D
    J Pharmacol Exp Ther; 1983 May; 225(2):284-90. PubMed ID: 6842392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
    Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
    Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestasis induced by sodium taurolithocholate in isolated hamster liver.
    King JE; Schoenfield LJ
    J Clin Invest; 1971 Nov; 50(11):2305-12. PubMed ID: 5096514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestatic action of somatostatin in the rat: effect on the different fractions of bile secretion.
    Ricci GL; Fevery J
    Gastroenterology; 1981 Sep; 81(3):552-62. PubMed ID: 6114014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the rat.
    Meyers M; Slikker W; Vore M
    J Pharmacol Exp Ther; 1981 Jul; 218(1):63-73. PubMed ID: 7241390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximal hepatic bilirubin transport in the rat during somatostatin-induced cholestasis and taurocholate-choleresis.
    Ricci GL; Cornelis M; Fevery J; De Groote J
    J Lab Clin Med; 1983 Jun; 101(6):835-46. PubMed ID: 6133900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate.
    Adinolfi LE; Utili R; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1984; 4(1):30-7. PubMed ID: 6229465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bile formation by high doses of taurocholate in the perfused rat liver.
    Herz R; Paumgartner G; Preisig R
    Scand J Gastroenterol; 1976; 11(7):741-6. PubMed ID: 996441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide.
    Gerk PM; Li W; Vore M
    Drug Metab Dispos; 2004 Oct; 32(10):1139-45. PubMed ID: 15280218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
    Durham S; Mack R; Vore M
    Drug Metab Dispos; 1985; 13(6):695-9. PubMed ID: 2867873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.